Breaking Electroweak Symmetry Strongly

The problem of electroweak symmetry breaking is reviewed with discussion of future relevant experimentation at LHC and $e^+e^-$ linear colliders. The possibility of strong electroweak symmetry breaking is examined in more detail, using the BESS (Breaking Electroweak Symmetry Strongly) model as a basis for the discussion. The formal constructions are briefly presented and the possible expectations at future colliders are summarized.Comment: 20 pages, LaTeX, UGVA-DPT 1994/04-846. To appear in the Memorial Volume for Professor Robert Marshak, edited by E.C.G. Sudarshan, World Scientific Publishing Compan

Impurity effects on Fabry-Perot physics of ballistic carbon nanotubes

We present a theoretical model accounting for the anomalous Fabry-Perot pattern observed in the ballistic conductance of a single-wall carbon nanotubes. Using the scattering field theory, it is shown that the presence of a limited number of impurities along the nanotube can be identified by a measurement of the conductance and their position determined. Impurities can be made active or silent depending on the interaction with the substrate via the back-gate. The conceptual steps for designing a bio-molecules detector are briefly discussed.Comment: 4 pages, 4 figure

Effective Lagrangian for Heavy and Light Mesons: Semileptonic Decays

We introduce an effective lagrangian including negative and positive parity heavy mesons containing a heavy quark, light pseudoscalars, and light vector resonances, with their allowed interactions, using heavy quark spin-flavour symmetry, chiral symmetry, and the hidden symmetry approach for light vector resonances. On the basis of such a lagrangian, by considering the allowed weak currents and by including the contributions from the nearest unitarity poles we calculate the form factors for semileptonic decays of $B$ and $D$ mesons into light pseudoscalars and light vector resonances. The available data, together with some additional assumptions, allow for a set of predictions in the different semileptonic channels, which can be compared with those following {}from different approaches. A discussion of non-dominant terms in our approach, which attempts at including a rather complete dynamics, will however have to wait till more abundant data become available.Comment: LaTeX (style article), 19 pages, UGVA-DPT 1992/11-790, BARI-TH/92-12

Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy

Background: Fibrosis may be considered the hallmark of systemic sclerosis (SSc), the end stage triggered by different pathological events. Transforming growth factor-β (TGF-β) and platelet-derived growth factor BB (PDGF-BB) are profibrotic molecules modulating myofibroblast differentiation and proliferation, respectively. There is evidence linking CD248 with these two molecules, both highly expressed in patients with SSc, and suggesting that CD248 may be a therapeutic target for several diseases. The aim of this work was to evaluate the expression of CD248 in SSc skin and its ability to modulate SSc fibrotic process. Methods: After ethical approval was obtained, skin biopsies were collected from 20 patients with SSc and 10 healthy control subjects (HC). CD248 expression was investigated in the skin, as well as in bone marrow mesenchymal stem cells (MSCs) treated with TGF-β or PDGF-BB, by immunofluorescence, qRT-PCR, and Western blotting. Finally, in SSc-MSCs, the CD248 gene was silenced by siRNA. Results: Increased expression of CD248 was found in endothelial cells and perivascular stromal cells of SSc skin. In SSc-MSCs, the levels of CD248 and α-smooth muscle actin expression were significantly higher than in HC-MSCs. In both SSc- and HC-MSCs, PDGF-BB induced increased expression of Ki-67 when compared with untreated cells but was unable to modulate CD248 levels. After CD248 silencing, both TGF-β and PDGF-BB signaling were inhibited in SSc-MSCs. Conclusions: CD248 overexpression may play an important role in the fibrotic process by modulating the molecular target, leading to perivascular cells differentiation toward myofibroblasts and interfering with its expression, and thus might open a new therapeutic strategy to inhibit myofibroblast generation during SSc

Surgery for atrial fibrillation using radiofrequency catheter ablation

AbstractObjectiveWe present the results obtained in 40 patients with chronic atrial fibrillation using direct intraoperative radiofrequency to perform atrial fibrillation surgery.MethodsBetween April 1995 and June 2002, 40 patients underwent surgery for atrial fibrillation using radiofrequency ablation and cardiac surgery at the Department of Cardiovascular Surgery of the University of Bologna. There were 8 men and 32 women with a mean age of 62 ± 11.6 years (range: 20 to 80 years).ResultsConcomitant surgical procedures were: mitral valve replacement (n = 13), mitral valve replacement plus tricuspid valvuloplasty (n = 11), combined mitral and aortic valve replacement (n = 8), and combined mitral and aortic valve replacement plus tricuspid valvuloplasty (n = 5). Moreover, 1 patient underwent tricuspid valvuloplasty plus atrial septal defect repair, another required aortic valve replacement plus coronary artery bypass graft, and a third underwent aortic valve replacement. After the mean follow-up time of 16.5 ± 2.5 months survival was 92.8% and the overall cumulative rate of sinus rhythm was 88.5%.ConclusionsWe conclude that the radiofrequency ablation procedure is a safe and effective means of curing atrial fibrillation with negligible technical and time requirements, allowing recovery of the sinus rhythm and atrial function in the great majority of patients with atrial fibrillation who underwent cardiac surgery (88.5% of our study population)

Role of endovascular repair in the management of late pseudo-aneurysms following open surgery for aortic coarctation.

n/

Transcatheter Mitral Valve-in-Valve Dislocation: A Rescue Strategy

In the transcatheter aortic valve replacement era, transapical valve-in-valve mitral valve implantation is considered an alternative treatment for high-risk patients with degenerated mitral bioprosthesis. We report an unusual strategy to remedy the potentially fatal complication of the mitral prosthesis migration into the aortic arch. The dislocated prosthesis was successfully stabilized in the aortic arch with a bare aortic stent, ensuring adequate perfusion of epiaortic vessels. \ua9 2018 The Society of Thoracic Surgeon

BioGlue® is not associated with polypropylene suture breakage after aortic surgery

Objective: We have encountered broken or damaged polypropylene sutures (Prolene®) at the anastomotic sites during aortic reoperations. Because a surgical sealant, bovine serum albumin-glutaraldehyde (BioGlue®), was used in previous aortic surgery in some of these cases, we undertook this in vitro study to evaluate whether the use of BioGlue® was associated with breakage of polypropylene sutures at the aortic anastomosis. Materials and methods: The broken polypropylene sutures, anastomotic sites and aortic tissue at the location of suture breakage were visually inspected and evaluated intraoperatively. Six human cadaveric aortic samples were incised circumferentially and anastomosed proximally to a valved conduit with running 4–0 polypropylene sutures (Prolene®). In the test group (n = 3), BioGlue® was applied directly to the Prolene® sutures at the anastomotic sites, while in the control group (n = 3) the anastomoses were not sealed with any surgical adhesive. The six samples were immersed in Dulbecco's phosphate buffered saline solution and mounted on a M-6 Six Position Heart Valve Durability Testing System and tested up to 120 million cycles for a 2-year period. During and upon completion of the testing, the integrity of Prolene® sutures, the anastomosis and aortic tissues was regularly assessed by visual inspection. Results: Intraoperative findings included a stretched and thin aortic wall (some with thrombus), a small cleft between the aortic tissue and the Dacron vascular graft. An excessive amount of BioGlue® was often found around the anastomosis, with cracking material, but no signs of mechanical damage were observed in these cases. Upon visual inspection during and after in vitro testing, there was no apparent damage to the polypropylene sutures on the interior or exterior of the aortic anastomoses in any of the samples. No difference was observed in the physical integrity of the polypropylene sutures at anastomotic lines, the anastomoses and aortic tissues between the test and control samples. Conclusions: The results of this study suggest that the use of BioGlue® was not associated with breakage of the polypropylene sutures at the anastomotic sites after aortic dissection repair